Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Paul R. Walker, Yukihiro Toi et al.|Cancer Immunology Immunotherapy|2020Cited by 97
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Paul R. Walker, Biagio Ricciuti et al.|Cancer Immunology Immunotherapy|2020Cited by 3